Nootropic Brain Stack: Selank + Semax + Cerebrolysin
Last updated: 2026-03-03
The Nootropic Brain Stack combines four neuropeptides — Selank, Semax, Cerebrolysin, and Dihexa — into a comprehensive protocol for cognitive enhancement, neuroprotection, and mental performance. This is an advanced stack designed for individuals seeking to optimize memory, focus, learning speed, and long-term brain health.
Each compound in this stack targets a different aspect of neurological function: Semax amplifies BDNF (brain-derived neurotrophic factor) for neuroplasticity, Selank modulates GABA and serotonin for anxiolysis and calm focus, Cerebrolysin provides a complex of neurotrophic peptides for broad neuroprotection, and Dihexa acts as a potent HGF (hepatocyte growth factor) mimetic for synaptogenesis.[1] The result is a multi-pathway approach to cognitive optimization that addresses both short-term performance and long-term brain maintenance.
This guide covers the complete protocol, dosing, synergy rationale, cycling recommendations, safety considerations, and research evidence. All information is for educational purposes only and does not constitute medical advice. For a head-to-head comparison of two key compounds, see our Semax vs. Selank comparison.
Compounds in This Stack
Selank
Anxiolysis, calm focus, GABA modulation, immune support
Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It is a modified analog of the endogenous immunomodulatory peptide tuftsin with an added Pro-Gly-Pro sequence for metabolic stability. Selank has regulatory approval in Russia as an anxiolytic and nootropic.[1]
Mechanism in this stack: Selank modulates GABAergic neurotransmission to produce anxiolytic effects without sedation — a critical feature for a cognitive stack where alertness must be preserved. It also influences serotonin metabolism, enhances IL-6 expression for neuroimmune support, and stabilizes enkephalins involved in stress resilience. In this stack, Selank provides the "calm focus" foundation that allows Semax and Dihexa to enhance cognition without anxiety or overstimulation.
| Parameter | Detail |
|---|---|
| Research Dosage | 250–500 mcg per day |
| Route | Intranasal (primary) or subcutaneous |
| Frequency | 1–2 times daily |
| Half-Life | ~15–20 minutes (rapid central uptake) |
| Onset | Anxiolytic effects within 10–15 minutes (intranasal) |
Semax
BDNF upregulation, neuroplasticity, focus and learning enhancement
Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) derived from the N-terminal fragment of adrenocorticotropic hormone (ACTH 4-10) with a Pro-Gly-Pro C-terminal extension for stability. Developed at the Institute of Molecular Genetics in Moscow, Semax has regulatory approval in Russia and Ukraine for cognitive disorders and stroke recovery.[2]
Mechanism in this stack: Semax is the primary neuroplasticity driver. It robustly upregulates BDNF expression in the hippocampus and prefrontal cortex — the brain regions most critical for memory formation and executive function. It also modulates dopaminergic and serotonergic systems, enhances attention and information processing speed, and has demonstrated neuroprotective effects against oxidative stress. In this stack, Semax provides the "performance boost" layer.
| Parameter | Detail |
|---|---|
| Research Dosage | 300–600 mcg per day (standard); up to 1 mg (N-Acetyl Semax variant) |
| Route | Intranasal (primary) or subcutaneous |
| Frequency | 1–3 times daily |
| Half-Life | ~30 minutes intranasal; longer for N-Acetyl variant |
| Onset | Cognitive effects noticeable within 15–30 minutes |
Cerebrolysin
Broad neuroprotection, neurotrophic factor complex, neuroregeneration
Cerebrolysin is a complex mixture of low-molecular-weight neuropeptides and free amino acids derived from porcine brain tissue through a standardized enzymatic process. It contains active fragments of multiple neurotrophic factors including CNTF, GDNF, and NGF-like peptides. Cerebrolysin has been approved in over 50 countries for stroke recovery, traumatic brain injury, and dementia.[3]
Mechanism in this stack: Cerebrolysin provides a broad-spectrum neurotrophic "cocktail" that supports neuronal survival, synaptic plasticity, and neurogenesis through multiple simultaneous pathways. Where Semax specifically upregulates BDNF and Dihexa targets HGF/c-Met, Cerebrolysin casts a wider net of neurotrophic support. It has demonstrated effects on mitochondrial function in neurons, amyloid-beta metabolism, and tau phosphorylation — making it the neuroprotective backbone of this stack.
| Parameter | Detail |
|---|---|
| Research Dosage | 5–10 mL per day (intramuscular) |
| Route | Intramuscular (primary); intravenous in clinical settings |
| Frequency | Once daily, 5 days per week |
| Cycle Pattern | 4-week cycles with 4–8 week breaks |
| Clinical Protocol | 10–30 mL IV daily x 20 days (clinical/supervised only) |
Dihexa
Synaptogenesis, HGF/c-Met activation, memory consolidation
Dihexa (N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide) is a synthetic hexapeptide analog of angiotensin IV developed at Washington State University. It is an extraordinarily potent HGF (hepatocyte growth factor) mimetic — estimated to be approximately 10 million times more potent than BDNF at promoting synaptogenesis in certain assays.[4]
Mechanism in this stack: Dihexa activates the HGF/c-Met receptor system to drive the formation of new synaptic connections between neurons. This synaptogenesis is the physical substrate of learning and memory — more synapses mean more capacity for information processing and storage. In this stack, Dihexa provides the "hardware upgrade" while Semax provides the "software optimization" through BDNF-mediated neuroplasticity. See our Dihexa vs. Semax comparison for a deeper look at how these compounds differ.
| Parameter | Detail |
|---|---|
| Research Dosage | 10–20 mg per day (oral) |
| Route | Oral (sublingual) or subcutaneous |
| Frequency | Once daily |
| Half-Life | Not fully characterized; effects persist beyond plasma half-life |
| Note | Limited human safety data — approach with caution |
How They Work Together
The Nootropic Brain Stack targets four complementary pathways of cognitive function: anxiolysis (Selank), neuroplasticity (Semax), broad neuroprotection (Cerebrolysin), and synaptogenesis (Dihexa). This multi-pathway approach addresses both immediate cognitive performance and long-term brain health maintenance.
Pathway 1: Calm Focus Foundation (Selank)
Anxiety and cognitive performance exist in an inverted-U relationship — moderate arousal optimizes performance, while excessive anxiety impairs it. Selank's GABAergic modulation provides anxiolysis without sedation, establishing the optimal arousal state for the other compounds to work. By stabilizing emotional tone and reducing stress-mediated cognitive interference, Selank prevents the overstimulation that can occur when stacking multiple nootropic compounds.[1]
Pathway 2: BDNF-Driven Neuroplasticity (Semax)
BDNF is the master regulator of synaptic plasticity in the adult brain. Semax's robust upregulation of BDNF in the hippocampus and prefrontal cortex enhances long-term potentiation (LTP) — the cellular mechanism of learning. Higher BDNF levels mean faster learning, stronger memory consolidation, and improved information processing speed. Semax also modulates dopamine metabolism, contributing to motivation and reward-driven learning.[2]
Pathway 3: Neurotrophic Support Network (Cerebrolysin)
While Semax focuses on BDNF, Cerebrolysin provides a complex mixture of neurotrophic factors that support neuronal survival, mitochondrial function, and synaptic maintenance. This broad-spectrum approach is particularly valuable for long-term brain health — it addresses the metabolic and structural foundations that determine whether the neuroplastic changes driven by Semax and Dihexa persist over time. Cerebrolysin's effects on amyloid metabolism and neuroinflammation also provide a neuroprotective dimension absent from the other compounds.[3]
Pathway 4: Synaptic Hardware Expansion (Dihexa)
Dihexa's activation of the HGF/c-Met system drives the physical formation of new synapses — essentially expanding the brain's "hardware" capacity for information processing. This complements Semax's BDNF-driven "software" optimization. Together, they represent both the formation of new neural connections (Dihexa) and the strengthening and refinement of existing ones (Semax). This dual approach to neural connectivity enhancement is what distinguishes this stack from simpler nootropic protocols.[4]
Why Four Compounds?
Each compound addresses a bottleneck the others do not. Selank prevents anxiety from limiting cognitive ceiling. Semax accelerates learning and processing. Cerebrolysin maintains the neuronal infrastructure. Dihexa expands synaptic capacity. Removing any one creates a gap in the cognitive optimization chain. That said, this is an advanced stack — beginners should start with a Selank + Semax combination before adding Cerebrolysin and Dihexa. See our Selank vs. Semax comparison and Cerebrolysin research review for individual compound deep-dives.
Researching peptides? We did the hard part.
Get our free Peptide Starter Kit — the 5 most researched compounds, simplified into one actionable guide.
Protocol & Dosage Schedule
Dosage Schedule
| Phase | Selank | Semax | Cerebrolysin | Dihexa | Duration |
|---|---|---|---|---|---|
| Introduction | 250 mcg intranasal AM | 300 mcg intranasal AM | — | — | Weeks 1–2 |
| Build Phase | 250–500 mcg intranasal AM | 300–600 mcg intranasal AM+PM | 5 mL IM daily (Mon–Fri) | — | Weeks 3–4 |
| Full Stack | 500 mcg intranasal AM | 600 mcg intranasal AM+PM | 5–10 mL IM daily (Mon–Fri) | 10–20 mg oral AM | Weeks 5–8 |
| Taper | 250 mcg as needed | 300 mcg AM only | 5 mL 3x/week | Discontinue | Weeks 9–10 |
Cycle Length
8–10 weeks for a full cycle. Selank and Semax can be used for extended periods (some Russian clinical protocols run 14+ days continuously), but Cerebrolysin should follow a 4-week on / 4–8 week off pattern. Dihexa, due to limited long-term safety data, should be limited to 4–6 weeks maximum per cycle. A full break of 4–6 weeks between complete stack cycles is recommended.
Timing & Administration
Morning protocol (primary dosing window):
- Upon waking: Selank 250–500 mcg intranasal — establishes calm, focused baseline
- 15 minutes later: Semax 300–600 mcg intranasal — layered on Selank's anxiolytic foundation
- With breakfast: Dihexa 10–20 mg oral/sublingual (during full stack phase)
- Morning: Cerebrolysin 5–10 mL intramuscular (during build and full stack phases)
Afternoon booster (optional):
- Semax 300 mcg intranasal — extends focus into the afternoon; administer before 3 PM to avoid sleep interference
Note: Do not administer Semax in the evening, as its dopaminergic effects may interfere with sleep onset. Selank can be used in the evening if needed for anxiety management, as its GABAergic effects support rather than impair sleep.
What to Expect
Cognitive enhancement is more subtle and cumulative than physical healing. Many users expect dramatic overnight changes but the reality is progressive improvement over weeks. The following timeline reflects commonly reported observations from experienced nootropic users.
| Timeframe | Expected Observations |
|---|---|
| Days 1–3 | Selank: reduced anxiety, calmer mental state. Semax: mild increase in alertness and verbal fluency. Some report mild headache during initial adjustment. |
| Weeks 1–2 | Improved focus duration and reduced mental fatigue. Better stress tolerance. Enhanced verbal recall and reading comprehension. These are primarily Selank + Semax effects. |
| Weeks 3–4 | Cerebrolysin addition brings subtle improvement in mental clarity and "brain energy." Working memory improvements become noticeable. Some users report enhanced dream vividness. |
| Weeks 5–8 | Full stack effects: improved learning speed, stronger memory consolidation, enhanced creative thinking. Dihexa's synaptogenic effects compound over time. Many users describe feeling "sharper" and more mentally resilient. |
| Post-cycle | Many cognitive improvements persist for 4–8 weeks after discontinuation, particularly those driven by structural changes (BDNF, synaptogenesis). Some users report that gains in learning ability and memory become semi-permanent with repeated cycles. |
Safety & Contraindications
Known Side Effects
This is an advanced stack combining four neuroactive compounds. While each has a generally favorable safety profile in available research, the combination increases the importance of careful dose titration and monitoring.
Selank reported side effects:
- Mild sedation at higher doses
- Nasal irritation (intranasal route)
- Fatigue (uncommon)
Semax reported side effects:
- Headache (most common, usually resolves within days)
- Mild irritability or overstimulation (dose-dependent)
- Nasal dryness or irritation
- Insomnia if taken too late in the day
Cerebrolysin reported side effects:
- Injection site pain (intramuscular)
- Dizziness
- Mild agitation
- Sweating, warmth sensation
Dihexa reported side effects:
- Limited human safety data — most evidence is preclinical
- Theoretical concern about uncontrolled cell growth due to HGF/c-Met activation
- Headache and mild GI discomfort (anecdotally reported)
Contraindications and Cautions
- Cancer history: Dihexa's HGF/c-Met activation and Cerebrolysin's neurotrophic factor content raise theoretical concerns about promoting growth in individuals with cancer history. Avoid this stack if you have any history of cancer — particularly brain tumors.
- Psychiatric medications: Semax modulates dopamine and serotonin systems. Selank modulates GABA. Use extreme caution when combining with antidepressants (SSRIs, SNRIs, MAOIs), antipsychotics, or benzodiazepines. Consult a psychiatrist before combining.
- Seizure disorders: Neuroactive peptides that alter excitatory/inhibitory balance may theoretically affect seizure threshold. Individuals with epilepsy or seizure history should avoid this stack.
- Pregnancy and breastfeeding: Absolutely contraindicated. No safety data for any compound during pregnancy or lactation.
- Age consideration: This stack is designed for adults (25+). Brain development continues until approximately age 25, and introducing potent neurotrophic compounds during development is not recommended.
Quality and Sourcing
Selank and Semax should be sourced from reputable suppliers with third-party purity testing (HPLC, 98%+). Cerebrolysin is a pharmaceutical product manufactured by EVER Pharma — obtain genuine pharmaceutical-grade product rather than compounded alternatives. Dihexa is a research compound with limited sourcing options; verify COA documentation carefully. All intranasal peptides should be reconstituted with preserved bacteriostatic sodium chloride solution appropriate for nasal use.
Important: Selank and Semax have regulatory approval in Russia but not in the United States or EU. Cerebrolysin is approved in 50+ countries but not in the US. Dihexa is a research compound without any regulatory approval. This information is for educational purposes only. Consult a qualified healthcare professional before using any peptide protocol.
Frequently Asked Questions
References
- Kozlovskii II, Danchev ND, Seredenin SB. Anxiolytic activity of the synthetic peptide selank. Bulletin of Experimental Biology and Medicine, 2003.
- Dolotov OV, Karpenko EA, Inozemtseva LS, et al.. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Research, 2006.
- Alvarez XA, Cacabelos R, Laredo M, et al.. A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease. European Journal of Neurology, 2006.
- McCoy AT, Benoist CC, Wright JW, et al.. Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents. Journal of Pharmacology and Experimental Therapeutics, 2013.
Researching peptides? We did the hard part.
Get our free Peptide Starter Kit — the 5 most researched compounds, simplified into one actionable guide.
Related Stacks
Individual Compound Guides
Peptides Insider Editorial Team
Our content is reviewed for accuracy and grounded in peer-reviewed research where available. We do not provide medical advice. Always consult a qualified healthcare professional.